Blue Jet Healthcare Ltd
Pharmaceuticals | Small Cap
Blue Jet Healthcare demonstrates a strong financial standing, particularly in solvency and profitability. The company efficiently manages its debt, showcasing high-interest coverage and minimal debt ratios. Profitability metrics, including gross profit margin, ROCE, ROE, and ROA, reflect robust earnings and efficient capital utilization. Growth indicators are generally positive, with strong revenue and asset growth, though earnings per share growth lags. Areas for attention include liquidity and efficiency, particularly inventory and receivables management. The company maintains a solid financial base for future growth, but improvements in operational efficiency and liquidity could further enhance its performance. Overall, Blue Jet Healthcare exhibits a financially stable profile with promising growth prospects, balanced by the need for enhanced working capital management.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio7.20
- Profitability Ratio10.00
- Efficiency Ratio2.50
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio0.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthNeutral
Blue Jet Healthcare demonstrates a strong financial standing, particularly in solvency and profitability. The company efficiently manages its debt, showcasing high-interest coverage and minimal debt ratios. Profitability metrics, including gross profit margin, ROCE, ROE, and ROA, reflect robust earnings and efficient capital utilization. Growth indicators are generally positive, with strong revenue and asset growth, though earnings per share growth lags. Areas for attention include liquidity and efficiency, particularly inventory and receivables management. The company maintains a solid financial base for future growth, but improvements in operational efficiency and liquidity could further enhance its performance. Overall, Blue Jet Healthcare exhibits a financially stable profile with promising growth prospects, balanced by the need for enhanced working capital management.
Overall Valuation Score
P/E RATIO (TTM)
N/A
Industry Median
19.41
Small Cap Median
18.08
P/E RATIO
0.26
P/B RATIO
N/A
Industry Median
1.98
Small Cap Median
2.03
P/S RATIO
12.55
Industry Median
2.06
Small Cap Median
1.64
Others
PEG RATIO
0.00
EV/EBITDA RATIO
29.82
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹359.95 as on Feb 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company exhibits strong growth in revenue and assets, indicating successful expansion and market penetration. However, the decline in earnings per share growth suggests challenges in translating revenue into profits. While the company is expanding its asset base and increasing revenues, it needs to focus on improving profitability to sustain growth. Addressing the factors affecting EPS growth will be crucial for ensuring long-term financial health.
| Growth Ratios | Mar 2021 |
|---|---|
| Revenue Growth Rate | N/A |
| Operating Profit Growth Rate | N/A |
| Earnings Per Share (EPS) Growth | N/A |
| Asset Growth Rate | N/A |
| Net Income Growth Rate | N/A |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios reflect a mixed performance. While adjusted EPS and capital expenditures are strong, cash EPS and book value per share are average. The low dividend per share suggests a conservative approach to shareholder returns. Overall, the company shows potential for improvement in shareholder value and efficient capital allocation. Optimizing these financial metrics will be crucial for enhancing long-term financial performance.
| Financial Ratios | Mar 2021 |
|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 27.2 |
| Cash Earnings Per Share (Cash EPS) | 31.2 |
| Book Value Per Share | 68 |
| Dividend Per Share (DPS) | 0 |
| Capital Expenditures (CapEx) | 0 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company showcases excellent profitability ratios, indicating strong earnings and efficient capital utilization. Its high gross profit margin, ROCE, ROE, and ROA reflect effective cost management and robust returns on investments. This profitability enables the company to sustain operations, invest in growth, and provide value to shareholders. These ratios collectively highlight the company's financial strength and competitive advantage.
| Profitability Ratios | Mar 2021 |
|---|---|
| Gross Profit Margin | 37.27 |
| Return on Capital Employed (ROCE) | 55.88 |
| Return on Equity (ROE) | 39.12 |
| Return on Assets (ROA) | 38.43 |
| Operating Margin | 41.28 |
| Net Margin | 27.25 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios suggest challenges in asset utilization. While the fixed asset turnover ratio is not measured, the low inventory turnover and extended receivable days indicate potential issues in managing inventory and collecting payments efficiently. Improving these areas could enhance the company's operational effectiveness and cash flow. Addressing these inefficiencies will be crucial for optimizing overall financial performance.
| Efficiency Ratios | Mar 2021 |
|---|---|
| Fixed Asset Turnover Ratio | N/A |
| Inventory Turnover Ratio | N/A |
| Receivables Turnover Ratio | N/A |
| Days Sales in Inventory Ratio | N/A |
| Receivable Days | N/A |
| Capital Turnover Ratio | N/A |
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
The company demonstrates excellent coverage ratios, indicating a strong ability to meet its financial obligations. The high-interest coverage ratio reflects a robust capacity to cover interest expenses with its earnings. This financial strength supports stability and reduces the risk of financial distress. The company's strong coverage ratios enhance its creditworthiness and provide a solid foundation for future growth.
| Coverage Ratios | Mar 2020 | Mar 2021 |
|---|---|---|
| Interest Coverage Ratio | 28.71 | 38 |
| Equity Dividend Coverage Ratio | N/A | N/A |
Interest Coverage Ratio
The company exhibits excellent solvency, indicating a strong ability to meet its long-term obligations. Its minimal debt ratios and high-interest coverage provide significant financial stability. This financial strength allows the company to manage its debt effectively and supports sustained operations and future growth. The company's robust solvency position enhances its creditworthiness and reduces financial risk.
| Solvency Ratios | Mar 2021 |
|---|---|
| Debt Ratio | 0 |
| Debt to Equity Ratio | 0 |
| Equity Ratio | 1 |
| Debt To Asset Ratio | 0 |
Debt Ratio
Debt to Equity Ratio
Interest Coverage Ratio
The company's liquidity position cannot be determined due to lack of data, which is a critical consideration for short-term financial health. A comprehensive analysis of current, quick, and cash ratios is essential to evaluate the company's ability to meet its immediate obligations. Without this information, it is not possible to assess the company's operational efficiency and financial stability.
| Liquidity Ratios | Mar 2021 |
|---|---|
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Cash Ratio | N/A |
| Operating Cash Flow Ratio | N/A |
Current Ratio
Quick Ratio
Cash Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Blue Jet Healthcare Ltd | 7.19 | 0.26 | Neutral | 206.00 | 17.59 | 136.00 |
The management of Blue Jet Healthcare exhibits a mixed performance profile. The company benefits from a substantial promoter holding, indicating strong alignment with shareholder interests and good operational efficiency reflected in healthy operating profit margins. However, there are concerns regarding declining sales growth and a high P/E ratio, which suggests potential overvaluation relative to earnings. Overall, the management's assessment is mixed, balancing notable strengths with areas needing attention to ensure sustained financial health and investor confidence.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | High Promoter Holding | 86.00% | Indicates strong promoter confidence |
| Operating Profit Margin | 31% | Demonstrates good operational efficiency | |
| CONS | Declining Sales Growth | -1.30% | Indicates potential challenges in revenue expansion |
| High P/E Ratio | 57.3 | The company may be overvalued compared to its earnings |
Financial Performance & Growth
Blue Jet Healthcare's financial performance reveals inconsistencies. Sales Growth % decreased by -1.30% in Mar 2024. The compounded sales growth for the past 3 years is 13%, but the TTM sales growth is -3%, suggesting a recent downturn. Though the OPM stands at 31%, indicating operational stability, the fluctuations in quarterly sales and profit introduce volatility. While net profit has increased from 145 Cr in Mar 2020 to 164 Cr in Mar 2024, these mixed signals warrant a cautious outlook on the company's financial trajectory.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Sales (Cr) | 538 | 499 | 683 | 721 | 712 |
| Sales Growth (%) | - | -7.30% | 36.99% | 5.49% | -1.30% |
Capital Efficiency & Returns
Blue Jet Healthcare's capital efficiency demonstrates reasonable returns. In Mar 2024, the ROCE was 30%. The ROE was 22% last year, suggesting effective returns on shareholder funds. However, the Cash Conversion Cycle stands at 206 days in Mar 2024, indicating a prolonged period to convert resources into cash. Although ROCE has decreased from 58% in Mar 2021 to 30% in Mar 2024, the company still exhibits moderate returns on capital employed.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| ROCE (%) | 58% | 52% | 35% | 30% |
Financial Health & Prudence
Blue Jet Healthcare's financial health is strong, characterized by minimal debt. Borrowings have decreased from 74 Cr in Mar 2020 to 3 Cr in Mar 2024. The company maintains a low Debt/Equity Ratio, reflecting prudent leverage. Consistent profit sharing is evident through dividends, with an 11% payout in Mar 2024. The debt management is robust, marked by decreasing borrowings and a low debt-to-equity ratio.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Borrowings (Cr) | 74 | 53 | 19 | 5 | 3 |
Shareholding & Ownership Structure
Blue Jet Healthcare's ownership structure is stable, with high promoter holding. From Dec 2023 to Sep 2024, promoter holding remained consistent at 86.00%. As of Sep 2024, FII holdings are 2.18%, DII holdings are 1.75%, and public holding is 10.06%. The high promoter holding indicates sustained confidence in the company's prospects.
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| Promoter Holding (%) | 86.00% | 86.00% | 86.00% | 86.00% |
Blue Jet Healthcare's risk profile is moderate. The company's working capital management reveals an increasing cash conversion cycle, potentially signaling operational inefficiencies. However, the company's minimal debt and high promoter holding mitigate some financial risks. The risk assessment is cautiously moderate, highlighting the need for attention to operational efficiencies.
Off-balance sheet exposure quantification
No off-balance sheet exposure is present in the provided data. The company's liabilities primarily consist of equity, reserves, and borrowings, all of which are transparently reported on the balance sheet.
Contingent liability evaluation
There is no specific data on contingent liabilities available.
Accounting quality red flags
No significant accounting red flags are apparent in the provided data. The financial statements show consistent application of accounting principles.
Working capital management
Working capital management indicates potential inefficiencies. The cash conversion cycle has increased from 110 days in Mar 2020 to 206 days in Mar 2024. Debtor days have increased from 80 days in Mar 2020 to 91 days in Mar 2024. Inventory days have increased from 120 days in Mar 2020 to 151 days in Mar 2024. Days payable have decreased from 90 days in Mar 2020 to 35 days in Mar 2024. The increasing cash conversion cycle indicates a longer time to convert resources into cash, potentially affecting liquidity.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Cash Conversion Cycle (Days) | 110 | 204 | 183 | 199 | 206 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10511.93Bullish
- SMA 20511.29Bullish
- SMA 50508.63Bullish
- EMA 10511.95Bullish
- EMA 20511.08Bullish
- EMA 50503.84Bullish
- DEMA 10512.32Bullish
- DEMA 20513.68Bearish
- DEMA 50517.82Bearish
- TEMA 10512.01Bullish
- TEMA 20511.77Bullish
- TEMA 50517.98Bearish
- MACD1.77Bearish
- ADX45.71Strong Trend
- IndicatorValueSignal
- RSI55.89Neutral
- CCI31.75Neutral
- ROC 9-0.14Bearish
- ROC 141.76Bullish
- ROC 251.49Bullish
- Stoch K29.75Neutral
- Stoch D26.66Neutral
- IndicatorValueSignal
- BB Upper519.74Neutral
- BB Middle511.29Neutral
- BB Lower502.84Neutral
- ATR5.79Low Volatility
- IndicatorValueSignal
- MFI73.19Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10511.35Bullish
- SMA 20509.58Bullish
- SMA 50489.66Bullish
- EMA 10511.20Bullish
- EMA 20507.68Bullish
- EMA 50493.75Bullish
- DEMA 10513.20Bullish
- DEMA 20516.33Bearish
- DEMA 50513.43Bullish
- TEMA 10512.18Bullish
- TEMA 20514.00Bearish
- TEMA 50519.23Bearish
- MACD5.91Bearish
- ADX52.03Strong Trend
- IndicatorValueSignal
- RSI59.43Neutral
- CCI64.01Neutral
- ROC 91.53Bullish
- ROC 141.11Bullish
- ROC 252.73Bullish
- Stoch K30.73Neutral
- Stoch D28.98Neutral
- IndicatorValueSignal
- BB Upper517.57Neutral
- BB Middle509.58Neutral
- BB Lower501.59Neutral
- ATR8.39Low Volatility
- IndicatorValueSignal
- MFI62.67Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10509.53Bullish
- SMA 20495.84Bullish
- SMA 50470.27Bullish
- EMA 10507.50Bullish
- EMA 20498.01Bullish
- EMA 50477.27Bullish
- DEMA 10515.44Bearish
- DEMA 20515.09Bearish
- DEMA 50506.16Bullish
- TEMA 10513.23Bullish
- TEMA 20518.79Bearish
- TEMA 50N/AN/A
- MACD12.66Bearish
- ADX35.35Strong Trend
- IndicatorValueSignal
- RSI61.36Neutral
- CCI58.06Neutral
- ROC 90.27Bullish
- ROC 149.45Bullish
- ROC 2514.98Bullish
- Stoch K71.09Neutral
- Stoch D73.02Neutral
- IndicatorValueSignal
- BB Upper538.25Neutral
- BB Middle495.83Neutral
- BB Lower453.42Neutral
- ATR14.16Low Volatility
- IndicatorValueSignal
- MFI86.47Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10494.30Bullish
- SMA 20478.58Bullish
- SMA 50452.37Bullish
- SMA 100419.68Bullish
- SMA 200511.58Bullish
- EMA 10497.24Bullish
- EMA 20482.62Bullish
- EMA 50457.78Bullish
- EMA 100460.24Bullish
- EMA 200507.21Bullish
- DEMA 10513.74Bearish
- DEMA 20505.58Bullish
- DEMA 50479.49Bullish
- DEMA 100422.26Bullish
- DEMA 200429.66Bullish
- TEMA 10517.51Bearish
- TEMA 20511.40Bullish
- TEMA 50510.22Bullish
- TEMA 100459.50Bullish
- TEMA 200379.37Bullish
- MACD17.89Bullish
- ADX30.41Strong Trend
- IndicatorValueSignal
- RSI63.37Neutral
- CCI98.44Neutral
- ROC 1414.77Bullish
- ROC 2516.89Bullish
- Stoch K80.91Overbought
- Stoch D81.96Overbought
- IndicatorValueSignal
- BB Upper529.10Neutral
- BB Middle478.58Neutral
- BB Lower428.06Neutral
- ATR22.77Low Volatility
- IndicatorValueSignal
- MFI88.47Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20412.45Bullish
- SMA 50563.76Bearish
- EMA 20452.15Bullish
- EMA 50517.24Bearish
- DEMA 20417.52Bullish
- DEMA 50451.68Bullish
- TEMA 20453.88Bullish
- TEMA 50N/AN/A
- MACD-18.19Bullish
- ADX28.43Strong Trend
- IndicatorValueSignal
- RSI50.90Neutral
- CCI-35.13Neutral
- ROC 1433.01Bullish
- ROC 25-3.54Bearish
- Stoch K76.66Neutral
- Stoch D68.77Neutral
- IndicatorValueSignal
- BB Upper502.44Overbought
- BB Middle412.45Neutral
- BB Lower322.46Neutral
- ATR53.79High Volatility
- IndicatorValueSignal
- MFI64.28Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6429.07Bullish
- SMA 12565.91Bearish
- SMA 24592.80Bearish
- EMA 6456.99Bearish
- EMA 12514.31Bearish
- EMA 24513.39Bearish
- DEMA 6397.58Bullish
- DEMA 12453.43Bearish
- DEMA 24N/AN/A
- TEMA 6404.50Bullish
- TEMA 12N/AN/A
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX32.36Strong Trend
- IndicatorValueSignal
- RSI52.52Neutral
- CCIN/AN/A
- ROC 2515.87Bullish
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper957.18Neutral
- BB Middle617.65Neutral
- BB Lower278.13Neutral
- ATR119.20Low Volatility
- IndicatorValueSignal
- MFI26.55Neutral